INVEX Ther (IXC) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

11 July 2019: Highest Dividend Yield stocks and ASX Broker Consensus scans updated. Join my email list for more goodies.

INVEX Ther Chart

Share price
Last
Change
Volume
Turnover
Market Cap $32.19 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

IXC Statistics

16 July

1,243 / 2,323

ASX Size Rank

1yr Return

vs Sector (1yr)

-15.55%

vs ASX 200 (1yr)

-10.59%

$32.19 million

Market Cap

Share Issue

31.25 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

16 July

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Invex Therapeutics Ltd (IXC) is a biopharmaceutical company, focused on the research and development of Exenatide as an efficacious treatment for neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke, hydrocephalus, venous sinus thrombosis, brain tumours, meningitis, secondary pseudo tumour cerebri and traumatic brain injury.

INVEX Ther Logo

Corporate Details

Head Office: Subiaco
Managing Director: -
GICS Sub-Industry: Pharmaceuticals
Date Listed: 5 Jul 2019
Registry: -
Similar Companies: MYX / SPL / CAN / MVP / NEU

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

IXC is not covered by a major broker.

Directors & Management

About the Data


Name Title Since Bio
Mr David McAuliffe Non-Executive Director Mar 2019
Ms Narelle Warren Company Secretary, Non-Executive Director Mar 2019
Dr Jason Loveridge Non-Executive Chairman, Non-Executive Director Mar 2019
Dr Alexandra J Sinclair Chief Scientific Officer, Executive Director Jun 2019

Director Transactions

About the Data

IXC directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code IXC in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Minderoo Group Pty Ltd 5,000,000 9.09%
Tisia Nominees Pty Ltd 4,000,000 7.27%
JK Nominees Pty Ltd 4,000,000 7.27%
Warambi Sarl 3,540,000 6.44%
Mr David Jerimiah Mcauliffe 3,225,001 5.86%
Oaktone Nominees Pty Ltd 3,225,000 5.86%
Alexandra Jean Sinclair 2,500,000 4.55%
The University of Birmingham 2,000,000 3.64%
Dr Jason Loveridge 1,566,000 2.85%
Bannaby Investments Pty Limited 1,250,000 2.27%
Cityscape Asset Pty Ltd 1,250,000 2.27%
Sunset Capital Management Pty Ltd 1,250,000 2.27%
Cabletime Pty Ltd 790,000 1.44%
Denlin Nominees Pty Ltd 775,000 1.41%
Webinvest Pty Ltd 625,000 1.14%
Ms Kathryan Mary Salkilld 523,000 0.95%
Ms Alexandra Loveridge 523,000 0.95%
Ms Sophie Alice Loveridge 523,000 0.95%
John Dahlsen Superannuation Fund Pty Ltd 500,000 0.91%
Godney Pty Ltd 500,000 0.91%
Alba Capital Pty Ltd 500,000 0.91%
Magaurite Pty Ltd 500,000 0.91%
Peter Kyros Pty Ltd 500,000 0.91%
Invia Custodian Pty Limited 500,000 0.91%
Blu Bone Pty Ltd 487,500 0.89%
Mimo Strategies Pty Ltd 350,000 0.64%
Ardroy Securities Pty Ltd 350,000 0.64%
Hammerhead Holdings Pty Ltd 257,500 0.47%
Cossack Holdings (Aus) Pty Ltd 250,000 0.45%
Mr Andrew Murray Gregor 250,000 0.45%
Dr Peter John Stow & Mrs Karen Dorothy Stow 250,000 0.45%
Mr Mark John Bahen & Mrs Margaret Patrica Bahen 250,000 0.45%
Mr Mark John Bahen & Mrs Margaret Patrica Bahen 250,000 0.45%
Mr Anthony Duncan Mcintosh 250,000 0.45%
Giokir Pty Ltd 250,000 0.45%
Mr Peter James Nixon 250,000 0.45%
Tets Pty Ltd 250,000 0.45%
Mr Alexander Stevenson Gregg & Mrs Tania Pauline Davies Gregg 200,000 0.36%
Philuchna Pty Ltd 200,000 0.36%
Miss Joyce Gladys Francis 187,500 0.34%
Ms Katharine Leigh Sands 187,500 0.34%
All other shareholders 19.97 %


The Top 20 Shareholders of IXC hold 80.03% of shares on issue.

IXC Share Price History

Date Close Change % Change Open High Low Volume Turnover

IXC Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Biopharmaceuticals.

Incorporated: --

Level 1, 38 Rowland St
Subiaco WA 6008


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.